Mesoblast Limited vs Snap On Incorporated — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Snap On Incorporated trades at $412.41 (market cap $21.30B). The key difference: Snap On Incorporated is far larger — about 9.6× Mesoblast Limited's market cap, and Snap On Incorporated pays a 2.37% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | SNA | |
|---|---|---|
Market Cap | $2.21B | $21.30B |
Sector | Technology | Technology |
52-Week High | $20.96 | $419.31 |
52-Week Low | $12.88 | $321.38 |
Enterprise Value | $2.21B | $20.93B |
Dividend Yield | — | 2.37% |
Trailing returns across standard periods
Latest headlines on both assets
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →